Resistant Hypertension.

Debbie Valsan, Umber Burhan, Geoffrey Teehan

Journal: Advances in experimental medicine and biology 2017;956():181-189

PMID: 27864800

Abstract

Conservatively, ten million people in the USA alone may suffer from RH and may be similarly prevalent elsewhere. Given the strong linear correlation between hypertension and cardiovascular outcomes, better control is paramount. We favor a multi-pronged approach. It may not suffice to address this by pharmacologic means only. Careful attention to modifiable risk factors, particularly sodium intake, adhering to a proper diet (i.e. DASH), and avoiding agents, i.e. non-steroidals, that can elevate the blood pressure, is key. Frequent follow up to establish the right treatment regimen and home blood pressuring monitoring can have a strong impact on control. Finally, consideration of device therapy may be a more viable option in the future.

Address: Lankenau Medical Center, Lancaster Avenue, Suite 130, Wynnewood, PA, USA, 19096.

DOI: 10.1007/5584_2016_38

Link outs

Free resources

Medical:

https://medlineplus.gov/bloodpressuremedicines.htm...

Other Literature Sources:

https://scite.ai/reports/27864800

Subscription / membership required

Full Text Sources:

https://dx.doi.org/10.1007/5584_2016_38

MeSH Terms: Antihypertensive Agents, Baroreflex, Blood Pressure, Carotid Sinus, Drug Resistance, Electric Stimulation Therapy, Humans, Hypertension, Implantable Neurostimulators, Kidney, Protective Factors, Renal Artery, Risk Assessment, Risk Factors, Risk Reduction Behavior, Sympathectomy, Treatment Outcome